Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1020: Outcomes of Patent Foramen Ovale Closure for Primary Stroke Prevention

Presenter: Girish Pathangey

October 28, 2025

Presentation TCT 2025

TCT 1344: Second Transcatheter Occluder Implantation for Patent Foramen Ovale Closure With Mixed Reality Support

Presenter: Adriana Zlahoda-Huzior

October 27, 2025

Presentation TCT 2025

TCT 312: Patent Foramen Ovale and Red Blood Cell Dysfunction: Quantifying Morphotype-Dependent Risk via Computational Fluid Dynamics

Presenter: Daniela Trabattoni

October 26, 2025

Presentation TCT 2025

TCT 306: Oxygen Desaturation During Stress Tests to Identify Migraineurs with Functionally Significant Patent Foramen Ovale

Presenter: Sammy Shaker

October 26, 2025

Presentation TCT 2025

TCT 307: 20-Year Follow-up After Patent Foramen Ovale Closure in Patients With Cryptogenic Embolism

Presenter: Pablo Vidal Calés

October 26, 2025

Presentation TCT 2025

TCT 305: The Landmark RESPECT Results Reaffirmed with Real-World Procedural and Safety Outcomes of Patent Foramen Ovale (PFO) Closure Using the AmplatzerTM PFO and AmplatzerTM TalismanTM Occluders

Presenter: Richard Smalling

October 26, 2025

Presentation TCT 2025

TCT 1934: Fully Percutaneous Thrombectomy for Clot-in-Transit Across a Patent Foramen Ovale in Massive Pulmonary Embolism

Presenter: Matteo Sturla

October 26, 2025

News Daily News

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

Todd Neale

April 23, 2025

News Daily News

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

L.A. McKeown

February 11, 2025

Advertisement

TCT 1020: Outcomes of Patent Foramen Ovale Closure for Primary Stroke Prevention

TCT 1344: Second Transcatheter Occluder Implantation for Patent Foramen Ovale Closure With Mixed Reality Support

TCT 312: Patent Foramen Ovale and Red Blood Cell Dysfunction: Quantifying Morphotype-Dependent Risk via Computational Fluid Dynamics

TCT 306: Oxygen Desaturation During Stress Tests to Identify Migraineurs with Functionally Significant Patent Foramen Ovale

TCT 307: 20-Year Follow-up After Patent Foramen Ovale Closure in Patients With Cryptogenic Embolism

TCT 305: The Landmark RESPECT Results Reaffirmed with Real-World Procedural and Safety Outcomes of Patent Foramen Ovale (PFO) Closure Using the AmplatzerTM PFO and AmplatzerTM TalismanTM Occluders

TCT 1934: Fully Percutaneous Thrombectomy for Clot-in-Transit Across a Patent Foramen Ovale in Massive Pulmonary Embolism

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content